Variation in false-negative rate of reverse transcriptase polymerase chain reaction–based SARS-CoV-2 tests by time since exposure LM Kucirka, SA Lauer, O Laeyendecker, D Boon, J Lessler Annals of internal medicine 173 (4), 262-267, 2020 | 1666 | 2020 |
Chimpanzees as an animal model for human norovirus infection and vaccine development K Bok, GI Parra, T Mitra, E Abente, CK Shaver, D Boon, R Engle, C Yu, ... Proceedings of the National Academy of Sciences 108 (1), 325-330, 2011 | 258 | 2011 |
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers EU Patel, EM Bloch, W Clarke, YH Hsieh, D Boon, Y Eby, RE Fernandez, ... Journal of Clinical Microbiology 59 (2), 10.1128/jcm. 02257-20, 2021 | 190 | 2021 |
Comparative evolution of GII. 3 and GII. 4 norovirus over a 31-year period D Boon, JE Mahar, EJ Abente, CD Kirkwood, RH Purcell, AZ Kapikian, ... Journal of virology 85 (17), 8656-8666, 2011 | 171 | 2011 |
Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011–2016 EU Patel, CL Thio, D Boon, DL Thomas, AAR Tobian Clinical Infectious Diseases 69 (4), 709-712, 2019 | 147 | 2019 |
B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus–associated acute liver failure P Farci, G Diaz, Z Chen, S Govindarajan, A Tice, L Agulto, S Pittaluga, ... Proceedings of the National Academy of Sciences 107 (19), 8766-8771, 2010 | 145 | 2010 |
Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences C Yu, D Boon, SL McDonald, TG Myers, K Tomioka, H Nguyen, RE Engle, ... Journal of virology 84 (21), 11264-11278, 2010 | 102 | 2010 |
Hepatitis E virus seroprevalence and correlates of anti-HEV IgG antibodies in the Rakai District, Uganda D Boon, AD Redd, O Laeyendecker, RE Engle, H Nguyen, P Ocama, ... The Journal of infectious diseases 217 (5), 785-789, 2018 | 20 | 2018 |
Use of hepatitis C virus (HCV) immunoglobulin G antibody avidity as a biomarker to estimate the population-level incidence of HCV infection EU Patel, AL Cox, SH Mehta, D Boon, CE Mullis, J Astemborski, ... The Journal of infectious diseases 214 (3), 344-352, 2016 | 18 | 2016 |
Limited coverage of hepatitis C virus testing in the United States, 2013–2017 EU Patel, SH Mehta, D Boon, TC Quinn, DL Thomas, AAR Tobian Clinical Infectious Diseases 68 (8), 1402-1405, 2019 | 16 | 2019 |
Antibody avidity-based approach to estimate population-level incidence of hepatitis C D Boon, V Bruce, EU Patel, J Quinn, AK Srikrishnan, S Shanmugam, ... Journal of hepatology 73 (2), 294-302, 2020 | 8 | 2020 |
Diversity of hepatitis C virus infection among HIV-infected people who inject drugs in India SS Solomon, D Boon, S Saravanan, AK Srikrishnan, CK Vasudevan, ... Virusdisease 30, 490-497, 2019 | 4 | 2019 |
Hepatitis C IgG antibody avidity as a biomarker to estimate population-level incidence EU Patel, AL Cox, SH Mehta, D Boon, C Mullis, J Astemborski, ... Journal of Infectious Diseases, 2016 | 2 | 2016 |
Curating the evidence about COVID-19 for frontline public health and clinical care: the novel coronavirus research compendium AD Redd, LS Peetluk, BA Jarrett, C Hanrahan, S Schwartz, A Rao, ... Public Health Reports 137 (2), 197-202, 2022 | 1 | 2022 |
Curating and translating the evidence about SARS-CoV-2 and COVID-19 for frontline public health and clinical care: The Novel Coronavirus Research Compendium (NCRC) AD Redd, L Peetluk, B Jarrett, C Hanrahan, S Schwartz, A Rao, A Jaffe, ... medRxiv, 2021 | 1 | 2021 |
Reply to MacDonald et al EU Patel, SH Mehta, D Boon, TC Quinn, DL Thomas, AAR Tobian Clinical Infectious Diseases 70 (3), 544-545, 2020 | | 2020 |
Variation in False Negative Rate of RT-PCR Based SARS-CoV-2 Tests by Time Since Exposure (preprint) L Kucirka, S Lauer, O Laeyendecker, D Boon, J Lessler | | 2020 |
Hepatitis Delta Estimates in the United States Revisited Reply EU Patel, CL Thio, D Boon, DL Thomas, AAR Tobian CLINICAL INFECTIOUS DISEASES 69 (10), 1834-1835, 2019 | | 2019 |
Reply to Soriano, Gómez-Gallego, and Corral EU Patel, CL Thio, D Boon, DL Thomas, AAR Tobian Clinical Infectious Diseases 69 (10), 1834-1835, 2019 | | 2019 |
The epidemiology of recent hepatitis C infection among persons who inject drugs D Boon Johns Hopkins University, 2018 | | 2018 |